Skip to main content

Eli Lilly and Company cash flow statement

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

In fiscal 2025 (the year to 31 Dec 2025), Eli Lilly and Company generated $16.81B of operating cash flow and $8.97B of free cash flow, after $7.84B of capital expenditure.

From Eli Lilly and Company's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Eli Lilly and Company cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$2.95B−$2.07B$4.33B$5.07B$4.35B$4.09B$4.68B$2.39B$2.41B$2.74B−$204.1M$3.23B$8.32B$6.19B$5.58B$6.24B$5.24B$10.59B$20.64B$27.58B
Depreciation & amortization−$1.05B$1.12B$1.30B$1.33B$1.37B$1.46B$1.45B$1.38B$1.43B$1.50B$1.57B$1.61B$1.23B$1.32B$1.55B$1.52B$1.53B$1.77B$2.00B$2.17B
Stock-based compensation−$282.0M$255.3M$368.5M$231.0M$147.4M$141.5M$144.9M$156.0M$217.8M$255.3M$281.3M$279.5M$312.4M$308.1M$342.8M$371.1M$629.0M$646.0M$626.0M$698.0M
Operating cash flow$5.15B$7.30B$4.34B$6.86B$7.23B$5.30B$5.74B$4.46B$2.96B$4.85B$5.62B$5.52B$4.84B$6.50B$7.37B$7.59B$4.24B$8.82B$16.81B$30.64B
Operating cash flow margin27.7%35.8%19.9%29.7%29.8%23.5%24.8%22.7%14.9%22.9%28.1%25.7%21.7%26.5%26.0%26.6%12.4%19.6%25.8%35.4%
Capital expenditures$1.08B$947.2M$765.0M$694.3M$672.0M$905.4M$1.01B$1.16B$1.07B$1.04B$1.08B$1.21B$1.03B$1.39B$1.31B$1.85B$3.45B$5.06B$7.84B$10.98B
Acquisitions$2.67B$6.08B$0.00$609.4M$307.8M$199.3M$43.70M$551.4M$5.28B$45.00M$882.1M$0.00$6.92B$849.3M$747.4M$327.2M————
Free cash flow$4.07B$6.35B$3.57B$6.16B$6.56B$4.40B$4.72B$3.30B$1.90B$3.81B$4.54B$4.31B$3.80B$5.11B$6.06B$5.73B$792.0M$3.76B$8.97B$19.66B
Free cash flow margin21.9%31.2%16.4%26.7%27.0%19.5%20.4%16.8%9.5%18.0%22.7%20.1%17.0%20.8%21.4%20.1%2.3%8.3%13.8%22.7%
Free cash flow per share—$5.80$3.25$5.57$5.89$3.94$4.35$3.07$1.78$3.59$4.31$4.17$4.06$5.60$6.64$6.34$0.88$4.16$9.98$21.96
Dividends paid$1.85B$2.06B$2.15B$2.17B$2.18B$2.19B$2.12B$2.10B$2.13B$2.16B$2.19B$2.31B$2.41B$2.69B$3.09B$3.54B$4.07B$4.68B$5.38B$5.98B
Gross share repurchases———$0.00$0.00$721.1M$1.70B$800.0M$749.5M$600.1M$299.8M$4.15B$4.40B$500.0M$1.25B$1.50B$750.0M$2.50B$4.11B$5.84B
Stock issuance proceeds——$200.0K$100.0K$400.0K———————————————
Net share repurchases——−$200.0K−$100.0K−$400.0K$721.1M$1.70B$800.0M$749.5M$600.1M$299.8M$4.15B$4.40B$500.0M$1.25B$1.50B$750.0M$2.50B$4.11B$5.84B
Cash interest paid—$203.1M$205.9M$176.3M$167.4M$171.9M$139.7M$140.4M$129.6M$146.4M$192.7M$223.8M$305.5M$345.8M$338.0M$323.7M$404.0M$578.0M$633.0M—
Free cash flow after SBC$3.79B$6.09B$3.20B$5.93B$6.42B$4.26B$4.58B$3.14B$1.68B$3.56B$4.26B$4.03B$3.49B$4.80B$5.71B$5.36B$163.0M$3.11B$8.35B$18.96B

Quarterly

Eli Lilly and Company cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$2.19B$2.24B$2.97B$970.3M$4.41B$2.76B$5.66B$5.58B$6.64B$7.40B$7.09B$6.45B
Depreciation & amortization$387.7M$400.6M$414.4M$466.8M$484.8M$463.0M$478.0M$470.0M$586.0M$509.0M$534.0M$545.0M
Stock-based compensation$120.2M$159.4M$211.1M$133.2M$141.9M$154.0M$185.0M$151.0M$136.0M$161.0M$201.0M$200.0M
Operating cash flow−$312.0M$1.17B$1.47B$3.71B$2.47B$1.67B$3.09B$8.84B$3.23B$5.33B$10.69B$11.40B
Operating cash flow margin−3.3%13.3%13.0%32.4%18.3%13.1%19.8%50.2%16.7%26.9%46.5%46.7%
Capital expenditures$1.07B$986.3M$1.22B$1.35B$1.50B$1.51B$1.70B$2.09B$2.55B$2.33B$2.93B$3.18B
Free cash flow−$1.38B$179.7M$241.4M$2.36B$977.8M$156.0M$1.39B$6.75B$678.0M$3.01B$7.76B$8.22B
Free cash flow margin−14.8%2.0%2.1%20.6%7.2%1.2%8.9%38.3%3.5%15.2%33.8%33.7%
Free cash flow per share−$1.53$0.20$0.27$2.61$1.08$0.17$1.54$7.51$0.75$3.36$8.68$9.20
Dividends paid$1.02B$1.17B$1.17B$1.17B$1.17B$1.35B$1.35B$1.35B$1.34B$1.55B$1.55B$1.54B
Gross share repurchases$0.00$0.00$0.00$446.1M$2.05B$1.20B$692.0M$708.0M$1.51B$2.36B$1.60B$377.0M
Net share repurchases$0.00$0.00$0.00$446.1M$2.05B$1.20B$692.0M$708.0M$1.51B$2.36B$1.60B$377.0M
Free cash flow after SBC−$1.50B$20.30M$30.30M$2.23B$835.9M$2.00M$1.21B$6.60B$542.0M$2.85B$7.56B$8.02B

The main figures as JSON and plain text. See data and methodology.

LLY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.